Treace Medical Concepts (TMCI) is jumping 7.5% after investment bank BTIG upgraded the shares to Buy from Neutral. Why BTIG Upgraded the Shares Treace provides technology that facilitates ...

Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) over the past 12 months. An insider's optimism about the company's prospects is a ...

Quite a few insiders have dramatically grown their holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) over the past 12 months. An insider's optimism about the company's prospects is a positive ...

Treace Medical Concepts, Inc. has a 1-year low of $3.92 and a 1-year high of $15.98. The company has a current ratio of 4.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.51.

announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation ...

John T. Treace, the CEO of Treace Medical Concepts, Inc. (NASDAQ:TMCI), has recently purchased additional shares of the company's common stock, according to a new SEC filing. On... ByInvesting.com ...

Investing.com - Treace Medical Concepts (NASDAQ: TMCI) reported third quarter EPS of $-0.28, $0.02 worse than the analyst estimate of $-0.26. Revenue for the quarter came in at ...

Scientists can estimate people's biological age, but whether they use oral tissue or blood to make the ... researchers and medical doctors can use biological age, which can be slowed or ...